NCT07331337

Brief Summary

Lateral epicondylitis is a prevalent musculoskeletal disorder, affecting 1-3% of the population, typically in middle age and without gender bias. Evidence on the role of scapular strengthening in managing pain, grip strength, and functional limitations in these patients remains limited. This study investigated the impact of scapular muscle strengthening combined with conventional therapy versus conventional therapy alone on these outcomes in individuals with chronic lateral epicondylitis. Thirty participants were randomly assigned to either a control group or an experimental group. Pain was assessed using the visual analogue scale, grip strength with a handheld dynamometer, and functional limitation with the patient-rated tennis elbow (PRTE) scale. The independent variables were the two treatment approaches: conventional therapy alone and conventional therapy supplemented with scapular strengthening.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 6, 2020

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 17, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 23, 2020

Completed
5.2 years until next milestone

First Submitted

Initial submission to the registry

December 28, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 9, 2026

Completed
Last Updated

January 12, 2026

Status Verified

January 1, 2026

Enrollment Period

7 months

First QC Date

December 28, 2025

Last Update Submit

January 8, 2026

Conditions

Keywords

Conventional TherapyScapular StrengthGrip StrengthFunctional AbilityPainLateral Epicondylitis

Outcome Measures

Primary Outcomes (1)

  • Pain at elbow

    Pain will be measured using the Visual Analogue Scale. This scale has a minimum value of 0 and a maximum value of 10. A higher score means a worse outcome.

    4 weeks

Secondary Outcomes (2)

  • Grip strength

    4 weeks

  • Functional difficulty

    4 weeks.

Study Arms (2)

Scapular Strengthening

EXPERIMENTAL

The experimental group received scapular strengthening in addition to conventional therapy.

Other: Scapular strengthening and conventional therapy

Conventional Therapy

ACTIVE COMPARATOR

The control group received conventional therapy.

Other: Conventional Therapy

Interventions

Scapular strengthening, along with conventional therapy that consisted of ultrasound therapy and static stretching.

Scapular Strengthening

Conventional therapy consisted of ultrasound therapy and static stretching.

Conventional Therapy

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Chronic lateral epicondylitis,
  • Positive Mill's test.

You may not qualify if:

  • Fracture in the shoulder, wrist, or elbow region,
  • Upper motor neurological disorder,
  • Fibromyalgia,
  • Cervical radiculopathy,
  • Recent burn,
  • Peripheral neuropathy,
  • Any surgery on the upper quadrant within six months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cooperative Institute of Health Sciences, Thalassery

Kannur, Kerala, 670105, India

Location

MeSH Terms

Conditions

Tennis ElbowPain

Condition Hierarchy (Ancestors)

Elbow TendinopathyTendinopathyMuscular DiseasesMusculoskeletal DiseasesElbow InjuriesArm InjuriesWounds and InjuriesTendon InjuriesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Masood Khan, M.P.Th.

    King Saud University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Researcher

Study Record Dates

First Submitted

December 28, 2025

First Posted

January 9, 2026

Study Start

March 6, 2020

Primary Completion

September 17, 2020

Study Completion

October 23, 2020

Last Updated

January 12, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations